Greg Bradley - 07 Apr 2022 Form 4 Insider Report for Petros Pharmaceuticals, Inc. (PTPI)

Role
Director
Signature
/s/ Mitchell Arnold, attorney-in-fact
Issuer symbol
PTPI
Transactions as of
07 Apr 2022
Net transactions value
$0
Form type
4
Filing time
11 Apr 2022, 17:00:56 UTC
Previous filing
07 Jan 2022
Next filing
25 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTPI Restricted Stock Units Award $0 +60,505 $0.000000 60,505 07 Apr 2022 Common Stock 60,505 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the right to receive, at settlement, one share of common stock of the Issuer.
F2 The restricted stock units vest on the one-year anniversary of the date of grant, subject to the reporting person's employment on that date.